Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001559053-14-000039
Filing Date
2014-06-06
Accepted
2014-06-06 16:24:01
Documents
5
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A prta201310-ka.htm 10-K/A 300992
2 LICENSE AGREEMENT WITH ROCHE prta201310-kaex104rochelic.htm EX-10.4 926121
3 EXHIBIT-CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 prta201310-kaxex313.htm EX-31.3 14469
4 EXHIBIT-CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 prta201310-kaxex314.htm EX-31.4 14535
5 EXHIBIT- SECTION 906 CERTIFICATION prta201310-kaxex322.htm EX-32.2 14706
  Complete submission text file 0001559053-14-000039.txt   1271892
Mailing Address 25-28 NORTH WALL QUAY DUBLIN L2 DUBLIN 1
Business Address 25-28 NORTH WALL QUAY DUBLIN L2 DUBLIN 1 650-615-2119
Prothena Corp plc (Filer) CIK: 0001559053 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-35676 | Film No.: 14896867
SIC: 2834 Pharmaceutical Preparations